These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8035664)

  • 1. Nitric oxide does not contribute to superoxide-mediated sulfhydryl oxidation in human polymorphonuclear leukocytes.
    Koshida H; Kotake Y
    Life Sci; 1994; 55(6):463-70. PubMed ID: 8035664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by superoxide anion in rat aorta.
    Mian KB; Martin W
    Br J Pharmacol; 1995 Jul; 115(6):993-1000. PubMed ID: 7582532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase inhibitors decrease human polymorphonuclear leukocyte luminol-dependent chemiluminescence.
    Catz SD; Carreras MC; Poderoso JJ
    Free Radic Biol Med; 1995 Dec; 19(6):741-8. PubMed ID: 8582646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide inhibits superoxide production by inflammatory polymorphonuclear leukocytes.
    Ródenas J; Mitjavila MT; Carbonell T
    Am J Physiol; 1998 Mar; 274(3):C827-30. PubMed ID: 9530115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide.
    Miles AM; Bohle DS; Glassbrenner PA; Hansert B; Wink DA; Grisham MB
    J Biol Chem; 1996 Jan; 271(1):40-7. PubMed ID: 8550595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial cells inhibit receptor-mediated superoxide anion production by human polymorphonuclear leukocytes via a soluble inhibitor.
    Basford RE; Clark RL; Stiller RA; Kaplan SS; Kuhns DB; Rinaldo JE
    Am J Respir Cell Mol Biol; 1990 Mar; 2(3):235-43. PubMed ID: 2155631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils in lung inflammation: Which reactive oxygen species are being measured?
    Azadniv M; Torres A; Boscia J; Speers DM; Frasier LM; Utell MJ; Frampton MW
    Inhal Toxicol; 2001 Jun; 13(6):485-95. PubMed ID: 11445888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives.
    Rubbo H; Radi R; Trujillo M; Telleri R; Kalyanaraman B; Barnes S; Kirk M; Freeman BA
    J Biol Chem; 1994 Oct; 269(42):26066-75. PubMed ID: 7929318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxylation of phenylalanine and salicylate by stimulated polymorphonuclear leukocytes and the accelerating effect of glutathione on their hydroxylation.
    Fujimoto S; Kawakami N; Ohara A
    Biol Pharm Bull; 1994 Jun; 17(6):767-72. PubMed ID: 7951135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-phenylenediamine oxidation by phorbol myristate acetate-stimulated human polymorphonuclear leukocytes: characterization of two distinct oxidative mechanisms.
    Hassan NF; Campbell DE; Douglas SD
    Clin Immunol Immunopathol; 1987 Mar; 42(3):274-80. PubMed ID: 3030588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide is not involved in hepatocyte killing by neutrophils activated by N-formyl-methionyl-leucylphenylalanine or phorbol myristate acetate in vitro.
    Wagner JG; Ganey PE; Roth RA
    Hepatology; 1996 Apr; 23(4):803-10. PubMed ID: 8666335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide anion production in glass-adherent polymorphonuclear leukocytes and its relationship to calcium movement.
    Rebut-Bonneton C; Bailly S; Pasquier C
    J Leukoc Biol; 1988 Nov; 44(5):402-10. PubMed ID: 2846729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.
    Radi R; Beckman JS; Bush KM; Freeman BA
    J Biol Chem; 1991 Mar; 266(7):4244-50. PubMed ID: 1847917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of heme proteins on nitric oxide levels and cell viability in isolated PMNs: a mechanism of toxicity.
    Cassidy RA; Burleson DG; Delgado AV; Kohler DJ; Salin ML; Pruitt BA
    J Leukoc Biol; 2000 Mar; 67(3):357-68. PubMed ID: 10733096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor.
    Chen LY; Lawson DL; Mehta JL
    Thromb Res; 1994 Nov; 76(4):317-22. PubMed ID: 7871491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-limiting enhancement by nitric oxide of oxygen free radical-induced endothelial cell injury: evidence against the dual action of NO as hydroxyl radical donor/scavenger.
    Az-ma T; Fujii K; Yuge O
    Br J Pharmacol; 1996 Oct; 119(3):455-62. PubMed ID: 8894164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental changes in endothelium-dependent vasodilation and the influence of superoxide anions in perinatal rabbit pulmonary arteries.
    Morecroft I; MacLean MR
    Br J Pharmacol; 1998 Dec; 125(7):1585-93. PubMed ID: 9884088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of superoxide anion by polymorphonuclear leukocytes from diabetic patients with or without diabetic retinopathy.
    Abu el-Asrar AM; Soliman RT; al-Amro SA; al-Shammary FJ
    Doc Ophthalmol; 1995-1996; 91(3):243-54. PubMed ID: 8886588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superoxide anion production by circulating polymorphonuclear leucocytes in rheumatoid arthritis.
    Cencetti A; De Martino M; Graziani E; Maddali Bongi S; Palermo C; Pavari E; Zoppi M
    Clin Rheumatol; 1990 Mar; 9(1):51-5. PubMed ID: 2159392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetaminophen inhibits the human polymorphonuclear leukocyte function in vitro.
    Shalabi EA
    Immunopharmacology; 1992; 24(1):37-45. PubMed ID: 1333457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.